PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-100.73%
Negative net income growth while CRON.TO stands at 183.62%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
4.09%
Less D&A growth vs. CRON.TO's 135.76%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
16.49%
Deferred tax of 16.49% while CRON.TO is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-1.73%
Negative yoy SBC while CRON.TO is 1.16%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-65.11%
Negative yoy working capital usage while CRON.TO is 211.92%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
113.18%
AR growth while CRON.TO is negative at -106.17%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-363.12%
Negative yoy inventory while CRON.TO is 542.66%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
60.91%
A yoy AP increase while CRON.TO is negative at -170.65%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-131.61%
Negative yoy usage while CRON.TO is 321.15%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
990.31%
Some yoy increase while CRON.TO is negative at -153.02%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
47.13%
Operating cash flow growth below 50% of CRON.TO's 564.16%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-65.54%
Both yoy lines negative, with CRON.TO at -600.33%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
99.91%
Acquisition growth of 99.91% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-161.81%
Negative yoy purchasing while CRON.TO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-68.75%
We reduce yoy sales while CRON.TO is 80.28%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
1734.95%
Growth well above CRON.TO's 194.56%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-64.46%
We reduce yoy invests while CRON.TO stands at 90.44%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
91.33%
Debt repayment growth of 91.33% while CRON.TO is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.